AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20522533 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 16
Study 18082502 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue PCI
Number of subjects: 221
Study 18082502 — intervention group
Group type: COMPARATOR
Intervention: Rescue eligible patients
Number of subjects: 221
Study 18082502 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency angiography before PCI
Number of subjects: 221
Study 16091920 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (SH) injection
Number of subjects: 90
Study 16091920 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamsinolone acetonide injection
Number of subjects: 90
Study 16091920 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy modalities
Number of subjects: 90
Study 16091920 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 90
Study 12924620 — intervention group
Group type: EXPERIMENTAL
Intervention: D10S537 marker
Number of subjects: 282
Study 11122943 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 10
Study 8728225 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-set disconnect system (Ultraset)
Number of subjects: 40
Study 8728225 — intervention group
Group type: COMPARATOR
Intervention: Conventional spike system
Number of subjects: 40
Study 2065536 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation radiotherapy
Number of subjects: 172
Study 2065536 — intervention group
Group type: COMPARATOR
Intervention: Routine fractionation radiotherapy
Number of subjects: 172
Study 6671106 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal artery constriction feedback
Number of subjects: 21
Study 6671106 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal artery dilation feedback
Number of subjects: 21
Study 6671106 — intervention group
Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 21
Study 30717815 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for antenatal depression
Number of subjects: 23
Study 30717815 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 23
Study 30176973 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 37
Study 30176973 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Pain (CBT-P)
Number of subjects: 37
Study 30176973 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 37
Study 26996051 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech and Gesture
Number of subjects: 135
Study 26996051 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech, Gesture and Face
Number of subjects: 135
Study 26996051 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech, Gesture and Face plus Instruction
Number of subjects: 135
Study 26996051 — intervention group
Group type: COMPARATOR
Intervention: Speech Only
Number of subjects: 135
Study 25034330 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of Cistiquer
Number of subjects: 60
Study 25034330 — intervention group
Group type: COMPARATOR
Intervention: Intra-vesical administration of betametasone 8 mg plus gentamicin 80 mg
Number of subjects: 60
Study 21505910 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose XLGB (3 g/day, n=61)
Number of subjects: 180
Study 21505910 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose XLGB (6 g/day, n=58)
Number of subjects: 180
Study 21505910 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CON group, n=61)
Number of subjects: 180
Study 20554078 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress cardiac MRI in an observation unit
Number of subjects: 110
Study 20554078 — intervention group
Group type: COMPARATOR
Intervention: Standard inpatient care
Number of subjects: 110
Study 18625763 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir at 400 mg twice daily for 4 days
Number of subjects: 0
Study 18625763 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) at 300 mg once daily for 7 days
Number of subjects: 0
Study 18625763 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir at 400 mg twice daily plus TDF at 300 mg once daily for 4 days
Number of subjects: 0
Study 18625763 — intervention group
Group type: COMPARATOR
Intervention: Raltegravir
Number of subjects: 0
Study 16143183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannulated patients
Number of subjects: 63
Study 16143183 — intervention group
Group type: EXPERIMENTAL
Intervention: Decannulated patients
Number of subjects: 63
Study 16143183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannulated and decannulated patients
Number of subjects: 63
Study 16143183 — intervention group
Group type: COMPARATOR
Intervention: Noncannulated patients
Number of subjects: 63
Study 11323536 — intervention group
Group type: EXPERIMENTAL
Intervention: TRT-100 (100 mg oral ketoprofen)
Number of subjects: 48
Study 11323536 — intervention group
Group type: EXPERIMENTAL
Intervention: TRT-25 (25 mg oral ketoprofen)
Number of subjects: 48
Study 11323536 — intervention group
Group type: COMPARATOR
Intervention: PLA (exercise + placebo)
Number of subjects: 48
Study 9389235 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretched technique
Number of subjects: 53
Study 9389235 — intervention group
Group type: COMPARATOR
Intervention: Unstretched technique
Number of subjects: 53
Study 7909525 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC) treatment
Number of subjects: 0
Study 7909525 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal intracellular glutathione levels (20-30 nmol/mg protein)
Number of subjects: 0
Study 7909525 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal intracellular glutathione levels (10-20 nmol/mg protein)
Number of subjects: 0
Study 3209275 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg, verapamil 80 mg, diltiazem 60 mg three times a day (calcium antagonists)
Number of subjects: 40
Study 3209275 — intervention group
Group type: COMPARATOR
Intervention: No drug (control group)
Number of subjects: 40
Study 3209275 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonists (Nifedipine, Verapamil, Diltiazem)
Number of subjects: 40
Study 30741642 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic Data Capture (EDC) tool
Number of subjects: 12
Study 30741642 — intervention group
Group type: COMPARATOR
Intervention: Paper-Pen Data Capture (PPDC)
Number of subjects: 12
Study 30741642 — intervention group
Group type: EXPERIMENTAL
Intervention: System Usability Scale (SUS) score for data collectors using EDC
Number of subjects: 12
Study 30741642 — intervention group
Group type: COMPARATOR
Intervention: Comparison of error rates between PPDC and EDC
Number of subjects: 12
Study 30741642 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative data response mapping for EDC
Number of subjects: 12
Study 27984524 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 884
Study 27984524 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 884
Study 27984524 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (exercise + CBT)
Number of subjects: 884
Study 25847895 — intervention group
Group type: EXPERIMENTAL
Intervention: SWL with simultaneous inclination (372 patients)
Number of subjects: 740
Study 25847895 — intervention group
Group type: COMPARATOR
Intervention: SWL alone (368 patients)
Number of subjects: 740
Study 22489839 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine-lying position at elbow flexion angle of 45 degrees
Number of subjects: 22
Study 22489839 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine-lying position at elbow flexion angle of 90 degrees
Number of subjects: 22
Study 22489839 — intervention group
Group type: COMPARATOR
Intervention: Prone-lying position at elbow flexion angle of 45 degrees
Number of subjects: 22
Study 22489839 — intervention group
Group type: COMPARATOR
Intervention: Prone-lying position at elbow flexion angle of 90 degrees
Number of subjects: 22
Study 21410107 — intervention group
Group type: EXPERIMENTAL
Intervention: AVI with postoperative subconjunctival bevacizumab (SCB) injections (days 1 and 7)
Number of subjects: 13
Study 21410107 — intervention group
Group type: COMPARATOR
Intervention: AVI without SCB (control group)
Number of subjects: 13
Study 21410107 — intervention group
Group type: EXPERIMENTAL
Intervention: AVI with SCB
Number of subjects: 13
Study 19617717 — intervention group
Group type: EXPERIMENTAL
Intervention: New-process PNEUMOVAX II
Number of subjects: 220
Study 19617717 — intervention group
Group type: COMPARATOR
Intervention: Former-process PNEUMOVAX II
Number of subjects: 220
Study 16464492 — intervention group
Group type: COMPARATOR
Intervention: Control group (E) - no composite build-up or post, teeth left empty
Number of subjects: 48
Study 16464492 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) - only resin composite build-up
Number of subjects: 48
Study 16464492 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC post without ferrule (0/FRC)
Number of subjects: 48
Study 16464492 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC post with ferrule (2/FRC)
Number of subjects: 48
Study 16464492 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium post without ferrule (0/T)
Number of subjects: 48
Study 16464492 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium post with ferrule (2/T)
Number of subjects: 48
Study 15013579 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based resources for smoking cessation
Number of subjects: 171
Study 15013579 — intervention group
Group type: COMPARATOR
Intervention: Standard written self-help materials
Number of subjects: 171
Study 11673930 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific manipulative therapy treatment
Number of subjects: 24
Study 11673930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 11673930 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 9442429 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of metronidazole 25% dental gel
Number of subjects: 24
Study 9442429 — intervention group
Group type: COMPARATOR
Intervention: Subgingival scaling
Number of subjects: 24
Study 7946496 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital at Home (HAH)
Number of subjects: 76
Study 7946496 — intervention group
Group type: COMPARATOR
Intervention: Control (hospital care only)
Number of subjects: 76
Study 3339790 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of folate plus 500 micrograms of hydroxocobalamin
Number of subjects: 73
Study 3339790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 28914087 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial therapy (12 sessions)
Number of subjects: 50
Study 28914087 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard physical therapy program + Myofascial therapy
Number of subjects: 50
Study 28914087 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy (12 sessions)
Number of subjects: 50
Study 26958799 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioembolization
Number of subjects: 1339
Study 26958799 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixator placement
Number of subjects: 1339
Study 26958799 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic angiography
Number of subjects: 1339
Study 26958799 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitative endovascular balloon occlusion of the aorta
Number of subjects: 1339
Study 26958799 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock group (systolic BP < 90 mm Hg or heart rate > 120 beats/min or base deficit < -5)
Number of subjects: 1339
Study 26958799 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic angioembolization in shock group
Number of subjects: 1339
Study 26958799 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiography in shock group
Number of subjects: 1339
Study 25222089 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple smaller units (served in Study 1)
Number of subjects: 129
Study 25222089 — intervention group
Group type: COMPARATOR
Intervention: Single larger unit (served in Study 1)
Number of subjects: 129
Study 25222089 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple units on separate plates (served in Study 2)
Number of subjects: 129
Study 25222089 — intervention group
Group type: COMPARATOR
Intervention: Single unit (served in both studies)
Number of subjects: 129
Study 23110878 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine
Number of subjects: 44
Study 23110878 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 44
Study 23110878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 23110878 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine and Varenicline
Number of subjects: 44
Study 23110878 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline and Nicotine
Number of subjects: 44
Study 21612625 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention
Number of subjects: 351
Study 21612625 — intervention group
Group type: COMPARATOR
Intervention: Brief intervention
Number of subjects: 351
Study 19916208 — intervention group
Group type: EXPERIMENTAL
Intervention: Early removal of bladder catheter (removed on the morning after surgery)
Number of subjects: 215
Study 19916208 — intervention group
Group type: COMPARATOR
Intervention: Standard care (bladder catheter removed when epidural analgesia was discontinued, 3-5 days later)
Number of subjects: 215
Study 19916208 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 215
Study 19916208 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with UTI
Number of subjects: 215
Study 16686645 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB) 600 mg/day
Number of subjects: 19
Study 16686645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 15220783 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic Labat approach (n = 25)
Number of subjects: 50
Study 15220783 — intervention group
Group type: COMPARATOR
Intervention: Lateral popliteal approach (n = 25)
Number of subjects: 50
Study 11741555 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dobutamine stress echocardiography (up to 40 micro/kg/min)
Number of subjects: 186
Study 11741555 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dobutamine stress echocardiography
Number of subjects: 186
Study 7587599 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) treatment, 3 x 10(6) U/day for 14 weeks
Number of subjects: 17
Study 7587599 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated with IFN)
Number of subjects: 17
Study 2794180 — intervention group
Group type: EXPERIMENTAL
Intervention: Television advertisement with letter announcing the campaign
Number of subjects: 96
Study 2794180 — intervention group
Group type: EXPERIMENTAL
Intervention: Television advertisement without letter announcing the campaign
Number of subjects: 96
Study 2794180 — intervention group
Group type: COMPARATOR
Intervention: No advertisement with letter announcing the campaign
Number of subjects: 96
Study 2794180 — intervention group
Group type: COMPARATOR
Intervention: No advertisement without letter announcing the campaign
Number of subjects: 96
Study 105697 — intervention group
Group type: EXPERIMENTAL
Intervention: Stannous fluoride toothpaste used twice yearly for three years in supervised brush-ins
Number of subjects: 492
Study 105697 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no intervention)
Number of subjects: 492
Study 31013820 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Citrate (CIT) 600 mg·kg‐1
Number of subjects: 20
Study 31013820 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 20
Study 28402983 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimonthly intravitreal injections of aflibercept (IVA)
Number of subjects: 58
Study 28402983 — intervention group
Group type: COMPARATOR
Intervention: Pro re nata (PRN) treatment
Number of subjects: 58
Study 28402983 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PRN and bimonthly)
Number of subjects: 58
Study 26690036 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration Training (WBVT) for 6 weeks, 3 sessions per week, intensity varied from 7.2 g to 32.6 g
Number of subjects: 64
Study 26690036 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 64
Study 25181050 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 20
Study 25181050 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 20
Study 25181050 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC
Number of subjects: 20
Study 25181050 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 20
Study 25181050 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 22083471 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMB (3 mg/kg once a day)
Number of subjects: 53
Study 22083471 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS (50 mg QD; day 1, 70 mg)
Number of subjects: 53
Study 22083471 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS-LAMB (combination therapy)
Number of subjects: 53
Study 22083471 — intervention group
Group type: COMPARATOR
Intervention: LAMB and CAS
Number of subjects: 53
Study 21051670 — intervention group
Group type: EXPERIMENTAL
Intervention: STARFlex septal closure system
Number of subjects: 910
Study 21051670 — intervention group
Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 910
Study 17613280 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat solid diet (LFSD)
Number of subjects: 121
Study 17613280 — intervention group
Group type: COMPARATOR
Intervention: Clear liquid diet (CLD)
Number of subjects: 121
Study 15769830 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 87
Study 15769830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 11932302 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 microg sodium selenite/d, orally, for 3 months)
Number of subjects: 70
Study 11932302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 11932302 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 70
Study 11932302 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation and Placebo
Number of subjects: 70
Study 9443459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 8916260 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation combined with methylpredonisolone (RT + MP)
Number of subjects: 38
Study 8916260 — intervention group
Group type: COMPARATOR
Intervention: Radiation alone (RT alone)
Number of subjects: 38
Study 1865159 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified conventional treatment (ICT)
Number of subjects: 96
Study 1865159 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment (RT)
Number of subjects: 96
Study 6353269 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 24
Study 6353269 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 24
Study 6353269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30611153 — intervention group
Group type: EXPERIMENTAL
Intervention: Bactiseal Universal Shunt (BUS)
Number of subjects: 248
Study 30611153 — intervention group
Group type: COMPARATOR
Intervention: Chhabra shunt
Number of subjects: 248
Study 29168264 — intervention group
Group type: EXPERIMENTAL
Intervention: Miracle fruit seed oil (MFSO) wristband
Number of subjects: 38
Study 29168264 — intervention group
Group type: COMPARATOR
Intervention: Vehicle wristband (control)
Number of subjects: 38
Study 29168264 — intervention group
Group type: EXPERIMENTAL
Intervention: MFSO wristband
Number of subjects: 38
Study 26387118 — intervention group
Group type: EXPERIMENTAL
Intervention: NTU P‐MSF self-assessment
Number of subjects: 120
Study 26387118 — intervention group
Group type: COMPARATOR
Intervention: NTU P‐MSF peer assessment
Number of subjects: 120
Study 26387118 — intervention group
Group type: EXPERIMENTAL
Intervention: NTU P‐MSF scores comparison
Number of subjects: 120
Study 26330893 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour turning schedule
Number of subjects: 942
Study 26330893 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hour turning schedule
Number of subjects: 942
Study 26330893 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour turning schedule
Number of subjects: 942
Study 26330893 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk participants
Number of subjects: 942
Study 26330893 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-risk participants
Number of subjects: 942
Study 26330893 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison of PrU incidence
Number of subjects: 942
Study 23853648 — intervention group
Group type: EXPERIMENTAL
Intervention: Face to face education
Number of subjects: 75
Study 23853648 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based education
Number of subjects: 75
Study 19922894 — intervention group
Group type: EXPERIMENTAL
Intervention: DPSGC 25 mg under fasted condition
Number of subjects: 47
Study 19922894 — intervention group
Group type: EXPERIMENTAL
Intervention: DPSGC 25 mg under fed condition
Number of subjects: 47
Study 19922894 — intervention group
Group type: EXPERIMENTAL
Intervention: DPSGC 50 mg under fasted condition
Number of subjects: 47
Study 19922894 — intervention group
Group type: EXPERIMENTAL
Intervention: DPSGC 50 mg under fed condition
Number of subjects: 47
Study 17329276 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 35
Study 17329276 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 35
Study 15704705 — intervention group
Group type: EXPERIMENTAL
Intervention: History of domestic violence
Number of subjects: 14100
Study 11248823 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% intraoperative daunorubicin for 3 minutes
Number of subjects: 60